FR177391, A New Anti-hyperlipidemic Agent from Serratia
Open Access
- 1 October 2005
- journal article
- research article
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 58 (10) , 640-647
- https://doi.org/10.1038/ja.2005.88
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- FR177391, A New Anti-hyperlipidemic Agent from SerratiaThe Journal of Antibiotics, 2005
- Pharmacological management of high triglycerides and low high-density lipoproetin cholesterolCurrent Opinion in Pharmacology, 2001
- Hypertriglyceridemia: A Review of Clinical Relevance and Treatment Options: Focus on CerivastatinCurrent Medical Research and Opinion, 2001
- The novel compound NO-1886 elevates plasma high-density lipoprotein cholesterol levels in hamsters and rabbits by increasing lipoprotein lipase without any effect on cholesteryl ester transfer protein activityMetabolism, 1997
- Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes.Journal of Clinical Investigation, 1995
- The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis.Journal of Clinical Investigation, 1993
- Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium.Journal of Clinical Investigation, 1989
- Fructose-induced insulin resistance and hypertension in rats.Hypertension, 1987
- Studies of the mechanism of fructose-induced hypertriglyceridemia in the ratMetabolism, 1982
- Effect of fructose feeding on insulin secretion and insulin action in the ratMetabolism, 1980